Positron emission tomography in premotor Parkinson's disease
References (26)
- et al.
Staging of brain pathology related to sporadic Parkinson' disease
Neurobiol Aging
(2003) - et al.
[18F]fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson' disease
Clin Neurol Neurosurg
(2003) - et al.
Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging
Nucl Med Commun
(2006) - et al.
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson' disease
Ann Neurol
(2000) - et al.
The role of inheritance in sporadic Parkinson' disease: evidence from a longitudinal study of dopaminergic function in twins
Ann Neurol
(1999) - et al.
Risk for Parkinson' disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET
J Neurol
(2000) - et al.
Positron emission tomography after MPTP: observations relating to the cause of Parkinson' disease
Nature
(1985) - et al.
Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP-treated monkeys: PET studies with [11C]raclopride
Synapse
(2002) - et al.
Corticostriatal functional interactions in Parkinson' disease: a rTMS/[11C]raclopride PET study
Eur J Neurosci
(2005) - et al.
Divergent expression of regional metabolic topographies in Parkinson' disease and normal ageing
Brain
(1997)
Hemiparkinsonism: Parallel longitudinal changes in hemispheric striatal DAT binding and glucose metabolism
Neurology
(2006)
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions
Ann Neurol
(1994)
PET in LRRK2 mutations: comparison to sporadic Parkinson' disease and evidence for presymptomatic compensation
Brain
(2005)
Cited by (0)
Copyright © 2007 Elsevier Ltd. All rights reserved.